QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Fredrik Borgström and Oskar Ström co-author report
Fredrik Borgström and Oskar Ström have co-authored a report studying the consequences of the recently introduced bundled payment model for hip and knee replacement in Stockholm. The study was conducted in collaboration between two research groups at Medical Management Center (MMC) at Karolinska Institutet and the Institute for Strategy and Competitiveness at Harvard Business School. The report (in Swedish) is available here.
Co-authored article in Thrombosis Research
Johan Mesterton co-authored an article in Thrombosis Research based on a study of the economic impact of different treatments in hemophiliac patients with inhibitors. The study used retrospective data from nationwide registries in the Czech Republic.
Link to article
Quantify Research website
The Quantify Research website is now also available on quantifyresearch.com. This is now the primary web and email address, while both .net and .se addresses are still functional.
Anders Gustavsson at conference in Toronto
Anders Gustavsson presented the current evidence on the economic burden of dementia at the 8th Geneva Association Health and Ageing Conference in Toronto. The topic of the conference was insurance and dementia and it gathered global expertise in life and health insurance, dementia care and health economics to exchange their knowledge and experience. The current economic burden of dementia is a global challenge which will continue to […]